Trial intelligence / Profile preview

Patient preference for fluticasone furoate vs fluticasone propionate in allergic rhinitis

NCT00398476Phase 3Completed

Sponsor
GSK
Start
Dec 2006
Primary completion
Dec 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone in allergic rhinitis (AR), sponsored by GSK. Started Dec 2006; status: completed.

02

Drugs

fluticasone
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT00398476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00398476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call